IDO2 and endometrial cancer: Importantly, Indoleamine 2, 3‐dioxygenase (IDO) is an intracellular enzyme whose increased activity demonstrates a negative correlation with the presence of tumour‐infiltrating lymphocytes (TILs) in cases of oesophageal and endometrial cancers.